Venture
Technologies
Therapeutic
Indication
Autoimmune & Inflammation
Basic Research
Cardiovascular Disease
Central Nervous System Disorders
Clinical Research
Developmental Disorders
Drug Discovery
Genetics & Genomics
Hematology
Metabolic Disease
Nephrology
Neurodegenerative Disease
Obesity
Oncology
Regenerative Medicine
CytoPropago’s technology activates a novel self-rejuvenation program in body cells, quickly reprogramming them into stem cells to reverse aging and support regenerative therapies.
CytoPropago Team: